Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$641.6K
13.25K shares
What this filing means
COUGHLIN TIMOTHY plans to sell 13.25K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $641.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2026ACC: 0001376043-26-000007
Director
Since May 2019
13.25K
Shares to sell
$641.6K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Options
N/A
5/9/2018
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/9/2018 | Stock Options N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.25K
Market value
$141.2K
5/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
10K
Market value
$500.4K
6/12/2026
Total
Units
13.25K
Value
$641.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/15/2026 | 3.25K | $141.2K | — | Completed |
| Planned — Approximate Date | ||||
6/12/2026 | 10K | $500.4K | Nasdaq | Planned |
| Total | 13.25K | $641.6K | ||